Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of ...

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these ...

Ozempic continues to grow in popularity in weight loss use. However, low-income patient populations who have an increased ...

With the government—meaning taxpayers and out-of-control borrowing—picking up the tab, third-party coverage is likely to drive much greater demand for Medicare-subsidized Ozempic and home ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

It's no surprise that campaigning for office is largely a matter of buying votes with unrealistic promises of largesse to be funded—if the promise is ever fulfilled—on the backs of those to be ...

The study funded by Novo Nordisk, the manufacturer of Ozempic and Wegovy ... taking a placebo reported an average pain score of 43.4. Medicare can pay for obesity drugs like Wegovy in certain ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

This list can have an impact on your drug coverage in 2025 and shows why this open enrollment is so important.